Characterization of pre-existing anti-PEG and anti-AGAL antibodies towards PRX-102 in patients with Fabry disease
Malte Lenders(University Hospital Münster), Eva Brand(University Hospital Münster)
Cited by 11
Related Papers
Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment
|Nature Reviews Cardiology|2015|140
Endothelial Dysfunction in Fabry Disease Is Related to Glycocalyx Degradation
|Frontiers in Immunology|2021|17